The seed money began at $1.5 million. The value of the deal could grow to an estimated $86 million dollars. The company's name is Tekmira Pharmaceuticals Corporation (TKMR) (TKM.TO), a leading developer of RNA interference (RNAi) therapeutics. "TKM-Ebola, an anti-Ebola virus RNAi therapeutic, is being developed under a $140 million contract with the U.S. Department of Defense's Medical Countermeasure Systems BioDefense Therapeutics (MCS-BDTX) Joint Product Management Office". As breaking and shocking of a news story as this has the potential to be, the real story is that this is not the most important part of the Ebola threat which has invaded the United States. The truth of the matter is that these unholy and untrustworthy associations, when it comes to "fighting" the Ebola virus, represent the mere tip of the iceberg.
The more on digs into who is behind the creation and the development of vaccines for treating Ebola, the more the conspiracy networks widen. The most amazing fact is how incredibly easy it was to locate this information.